Our Q2 2026 results will be published on August 6, 2026, at 7 a.m. (CEST). Our conference call for the media will take place at 09:30 a.m. (CEST), and the conference call for analysts at 2 p.m. (CEST)
Select your Market
-
{{ userContent.title }}
{{ userContent.lookingForMoreLabel }}
Investors
Welcome to our Investor Relations
Here you’ll find everything you might be interested in if you want to invest in vibrant science and technology.
-
Reasons to invest
Read MoreWe are a vibrant science and technology leader, combining expertise in biology, chemistry and physics with data and AI. With cutting-edge products and solutions enabled by integrated, platformed capabilities, we deliver sustainable value and growth for our stakeholders and society.
-
Sustainability
Read moreFor us, scientific progress and responsible entrepreneurship go hand in hand, enabling us to create a sustainable future for everyone
-
Reports & Financials
Read MoreMerck KGaA, Darmstadt, Germany, keeps growing profitably. The excellent performance of our business shows that we are on the right track. See for yourself in our comprehensive reports and financials.
Upcoming Events
View All EventsOur Q3 2026 results will be published on November 12, 2026, at 7 a.m. (CEST). Our conference call for the media will take place at 09:30 a.m. (CEST), and the conference call for analysts at 2 p.m. (CEST)
Investor Related News
View All News-
Press Releases
MilliporeSigma Announces BioReliance® Testing Facility Opening in ...
MilliporeSigma's new €25M BioReliance® facility in Darmstadt expands release and stability testing for biopharma companies in Europe.
2026/07/16
-
Press Releases
European Commission Approves Erbitux® (cetuximab) in Combination ...
Merck KGaA, Darmstadt, Germany, announced that the European Commission (EC) approved an update to the Erbitux (cetuximab) EU label on June 26, 2026.
2026/07/14
-
Press Releases
Merck KGaA, Darmstadt, Germany, Announces FDA Breakthrough Therapy Designation ...
The Company announced that the FDA has granted Breakthrough Therapy designation to enpatoran
2026/07/08
Share Price
Our interactive Share Price Tool provides you with all the information you need. You can retrace our development within the last ten years or follow it in real time – or compare our share price to various indices.
Check Share Price
Capital Market Days
Learn MoreCapital Market Days
At our Capital Market Days, our shareholders have the opportunity to meet our management and gain insights into our success story. We inform investors about our strategy, the latest financial developments and about our plans for the future.
Webcasts & Presentations
Learn MoreWebcasts & Presentations
There is a large number of presentations and webcasts of different events available for download. They provide helpful insights into our company, our businesses and executives as well as our financial development.
Annual General Meeting
Learn MoreAnnual General Meeting
Every year, our shareholders come together to make important decisions on our company’s business. We provide comprehensive material to help them make well-informed voting decisions.
Get in touch!
We're here to help. Get in touch if you have any questions.
+49 6151 72 3321
+49 6151 72 91 3321